---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-132450"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2023-05-02T23:59:59+00:00"
generated_at: "2026-06-16T03:06:00.102822+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MiMedx Q1 net sales $71.7M (+21.7% YoY); net loss narrows to $5.0M; Adj. EBITDA $5.5M

## Summary
- Net sales $71.7M in Q1 2023, up 21.7% from $58.9M in Q1 2022.
- Net loss improved to $5.0M from $10.5M in prior year; Adjusted EBITDA of $5.5M.
- CEO attributed growth to robust demand for new surgical products and accelerated growth in private physician offices.
- Gross margin improved sequentially; operating expenses grew slower than sales.
- Company also announced an upcoming Chief Financial Officer transition.

## SEC filing metadata
- accession: 0001193125-23-132450
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2023-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/0001193125-23-132450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/d79375d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-132450
- JSON: https://secwatch.observer/filing/0001193125-23-132450.json
- Plain text: https://secwatch.observer/filing/0001193125-23-132450.txt

## Key facts
- Earnings Releases
  MIMEDX GROUP, INC. reported first quarter 2023 results: revenue $71.7 million, net income net loss of $5.0 million.
  - Period: first quarter 2023
  - Revenue: $71.7 million
  - Net income: net loss of $5.0 million
  - Result: reported results
  source text: announced operating and financial results for the first quarter 2023, which ended March 31, 2023, including net sales of $71.7 million, net loss of $5.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/0001193125-23-132450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.